Dividends CalendarEarnings Calendar
NTLA

NTLA | Intellia Therapeutics Inc

Intellia Therapeutics Inc
Category: Biotechnology company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 4.67B
  • Prev closed: 13.36
  • Open: 13.87
  • High: 13.91
  • Low: 13.37
  • 52 week low: 9.18
  • 52 week high: 19
  • Dividends:No Dividends

Next ER: February 25, 2021  Before Market Opens



Top Stories (NTLA)

    About the Company

    Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 4, 2021
    February 25, 2021-0.69 / -0.60676.6M / 13.14M
    November 5, 2020-0.47 / -0.590822.22M / 14.9MBeat!
    August 6, 2020-0.61 / -0.6916.26M / 9.53MBeat!
    May 7, 2020-0.63 / -0.4512.92M / 20.25M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Feb 26, 2021 60.46 59.24
    63.00
    56.53
    2.38M 5.20%
    Feb 25, 2021 57.47 62.53
    68.15
    56.60
    2.06M -9.81%
    Feb 24, 2021 63.72 62.84
    65.75
    59.67
    1.28M 0.24%
    Feb 23, 2021 63.57 62.87
    64.80
    56.88
    1.99M -3.91%
    Feb 22, 2021 66.16 70.35
    71.70
    65.70
    1.35M -8.58%
    Feb 19, 2021 72.37 68.00
    73.37
    67.51
    1.25M 8.65%
    Feb 18, 2021 66.61 65.77
    68.48
    64.00
    1.25M -3.18%
    Feb 17, 2021 68.80 66.91
    68.81
    63.39
    1.16M 0.95%
    Feb 16, 2021 68.15 68.73
    70.30
    67.69
    1.27M -0.19%
    Feb 12, 2021 68.28 68.50
    70.02
    66.07
    977.41K -0.93%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:104

    News

    News for (NTLA)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Nessan Bermingham, PhD
    • General Counsel :  José Rivera

    Talk about Intellia Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Feb 25, 2021 (Same day)

    hpq crm fslr bby adsk dpz w rmax ntes.ch swn edit vmw 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 25
    HOLD 75
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInInstagram

    Peers / Similar stocks 

    xlv 

    Other stocks 

    ibm tgt aap sig pdco azo tvpt low afsi amg cgc docu 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!